8 results on '"Buvelot H"'
Search Results
2. Souvenir du 30 août 1838, dédié à S. A. Ser. A. D. Ghika, prince régnant de Valachie, par H. Buvelot et G. Storhas
- Author
-
Storhas, G.. Auteur du texte, Buvelot, H.. Auteur du texte, Storhas, G.. Auteur du texte, and Buvelot, H.. Auteur du texte
- Abstract
Avec mode texte
3. Souvenir du 30 août 1838, dédié à S. A. Ser. A. D. Ghika, prince régnant de Valachie, par H. Buvelot et G. Storhas
- Author
-
Storhas, G.. Auteur du texte, Buvelot, H.. Auteur du texte, Storhas, G.. Auteur du texte, and Buvelot, H.. Auteur du texte
- Abstract
Avec mode texte
4. First report of uncommon mycobacteria in post LASIK keratitis: Mycobacterium wolinskyi.
- Author
-
van Delden S, Buvelot H, Bravetti GE, Pham TT, Thumann G, and Massa H
- Abstract
Laser assisted in situ keratomileusis (LASIK) surgery is the leading and most performed refractive surgery nowadays. A possible complication of LASIK surgery is infectious keratitis which can lead to disastrous corneal damage and result in permanent loss of vision. LASIK procedures have become increasingly accessible, and the demand for refractive surgery has risen among patients, challenging the medical field to improve the prevention of post-operative infections. Nevertheless, a wide range of pathogens have been described as responsible for post-LASIK keratitis. However, non-tuberculous mycobacterial keratitis remains an infrequent occurrence and is poorly described in the literature. To the best of our knowledge, this is the first ever reported case of post-LASIK keratitis caused by Mycobacterium wolinskyi. We describe the clinical and microbial characteristics, leading to its challenging treatment choice., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
5. Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years.
- Author
-
Schoepf IC, Esteban-Cantos A, Thorball CW, Rodés B, Reiss P, Rodríguez-Centeno J, Riebensahm C, Braun DL, Marzolini C, Seneghini M, Bernasconi E, Cavassini M, Buvelot H, Thurnheer MC, Kouyos RD, Fellay J, Günthard HF, Arribas JR, Ledergerber B, and Tarr PE
- Subjects
- Male, Humans, Aged, Female, Longitudinal Studies, Cohort Studies, Switzerland epidemiology, Aging genetics, Epigenesis, Genetic, Leukocytes, Mononuclear, HIV Infections drug therapy, HIV Infections epidemiology, HIV Infections genetics
- Abstract
Background: Accelerated epigenetic ageing can occur in untreated HIV infection and is partially reversible with effective antiretroviral therapy (ART). We aimed to make a long-term comparison of epigenetic ageing dynamics in people with HIV during untreated HIV infection and during suppressive ART., Methods: In this longitudinal study, conducted over 17 years in HIV outpatient clinics in Switzerland, we applied 5 established epigenetic age estimators (epigenetic clocks) in peripheral blood mononuclear cells (PBMCs) in Swiss HIV Cohort Study participants before or during suppressive ART. All participants had a longitudinal set of PBMC samples available at four timepoints (T1-T4). T1 and T2 had to be 3 years or longer apart, as did T3 and T4. We assessed epigenetic age acceleration (EAA) and a novel rate of epigenetic ageing., Findings: Between March 13, 1990, and Jan 18, 2018, we recruited 81 people with HIV from the Swiss HIV Cohort Study. We excluded one participant because a sample did not meet quality checks (transmission error). 52 (65%) of 80 patients were men, 76 (95%) were white, and the median patient age was 43 (IQR 37·5-47) years. Per year of untreated HIV infection (median observation 8·08 years, IQR 4·83-11·09), mean EAA was 0·47 years (95% CI 0·37 to 0·57) for Horvath's clock, 0·43 years (0·3 to 0·57) for Hannum's clock, 0·36 years (0·27 to 0·44) for SkinBlood clock, and 0·69 years (0·51 to 0·86) for PhenoAge. Per year of suppressive ART (median observation 9·8 years, IQR 7·2-11), mean EAA was -0·35 years (95% CI -0·44 to -0·27) for Horvath's clock, -0·39 years (-0·50 to -0·27) for Hannum's clock, -0·26 years (-0·33 to -0·18) for SkinBlood clock, and -0·49 years (-0·64 to -0·35) for PhenoAge. Our findings indicate that people with HIV epigenetically aged by a mean of 1·47 years for Horvath's clock, 1·43 years for Hannum's clock, 1·36 years for SkinBlood clock, and 1·69 years for PhenoAge per year of untreated HIV infection; and 0·65 years for Horvath's clock, 0·61 years for Hannum's clock, 0·74 years for SkinBlood clock, and 0·51 years for PhenoAge, per year of suppressive ART. GrimAge showed some change in the mean EAA during untreated HIV infection (0·10 years, 0·02 to 0·19) and suppressive ART (-0·05 years, -0·12 to 0·02). We obtained very similar results using the rate of epigenetic ageing. Contribution of multiple HIV-related, antiretroviral, and immunological variables, and of a DNA methylation-associated polygenic risk score to EAA was small., Interpretation: In a longitudinal study over more than 17 years, epigenetic ageing accelerated during untreated HIV infection and decelerated during suppressive ART, highlighting the importance of limiting the duration of untreated HIV infection., Funding: Swiss HIV Cohort Study, Swiss National Science Foundation, and Gilead Sciences., Competing Interests: Declaration of interests ICS received a lecture fee to institution from ViiV, outside the submitted work. BR declares personal fees from Gilead and non-financial support from ViiV Healthcare, outside the submitted work. DLB reports honoraria paid to himself for advisory boards and lectures from Gilead, Merck, and ViiV, outside the submitted work. CM declares personal fees from ViiV, MSD, and Pfizer, outside the submitted work. EB received consultant fees and travel grants to institution from Gilead Sciences, MSD, ViiV, Pfizer, AbbVie, Ely Lilly, and Moderna, outside the submitted work. HFG has been an adviser or member of a drug safety monitoring board (with personal fees), outside of the submitted work for Merck, Gilead Sciences, ViiV, GSK, Janssen, Johnson & Johnson, and Novartis and has received unrestricted research grants and a travel grant from Gilead Sciences. JRA has received personal fees from Gilead, Janssen, ViiV, MSD, Aelix, and Theranos, outside the submitted work. BL received personal fees from Kantonsspital Baselland, Liestal, Switzerland, during the conduct of the study, and reports personal fees from Gilead, outside the submitted work. PET received grants, and educational and advisory fees to institution from Gilead, MSD, and ViiV, outside the submitted work. All other authors declare no competing interests., (Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
6. Hydrogen Peroxide Affects Growth of S. aureus Through Downregulation of Genes Involved in Pyrimidine Biosynthesis.
- Author
-
Buvelot H, Roth M, Jaquet V, Lozkhin A, Renzoni A, Bonetti EJ, Gaia N, Laumay F, Mollin M, Stasia MJ, Schrenzel J, François P, and Krause KH
- Subjects
- Bacterial Proteins metabolism, Cells, Cultured, Down-Regulation, Humans, Neutrophils microbiology, Reactive Oxygen Species metabolism, Gene Expression Regulation, Bacterial drug effects, Hydrogen Peroxide pharmacology, Pyrimidines metabolism, Staphylococcus aureus drug effects, Staphylococcus aureus metabolism
- Abstract
Reactive oxygen species (ROS) play a crucial role in the cellular defense against S. aureus , as evidenced by the importance of this pathogen in patients lacking the ROS-generating phagocyte NADPH oxidase NOX2. ROS concentrations required to kill S. aureus in vitro are much higher than those found in the phagosome. We therefore hypothesized that sublethal ROS concentrations may play a role in S. aureus gene dysregulation and investigated the in vitro transcriptomic response of S. aureus to sublethal concentrations of hydrogen peroxide (H
2 O2 ). A striking observation of these experiments was a coordinated and massive downregulation of genes involved in pyrimidine metabolism. Using transposon insertion mutants, we demonstrated that deletion of carA , a gene involved in pyrimidine synthesis, led to a significant growth defect and to an increased sensitivity of S. aureus to added H2 O2 . The phenotype of the carA mutant could be reversed through supplementation with the pyrimidine precursor uracil, or with a multicopy vector encoding carA . As opposed to the impact of ROS on extracellular survival, carA deletion did not affect the intracellular survival in neutrophils. Our results raise the possibility that ROS-dependent downregulation of pyrimidine metabolism might be a survival strategy of S. aureus , allowing colonization through intracellular survival, while decreasing the risk of killing the host through dampened extracellular growth., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Buvelot, Roth, Jaquet, Lozkhin, Renzoni, Bonetti, Gaia, Laumay, Mollin, Stasia, Schrenzel, François and Krause.)- Published
- 2021
- Full Text
- View/download PDF
7. Caring for people living with HIV during the global coronavirus disease 2019 pandemic.
- Author
-
Nawej Tshikung O, Smit M, Marinosci A, Buvelot H, Valladares P, Do-Co Lecompte T, Flammer Y, and Calmy A
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, COVID-19, Delivery of Health Care organization & administration, HIV Infections therapy, Pandemics
- Published
- 2021
- Full Text
- View/download PDF
8. Staphylococcus aureus, phagocyte NADPH oxidase and chronic granulomatous disease.
- Author
-
Buvelot H, Posfay-Barbe KM, Linder P, Schrenzel J, and Krause KH
- Subjects
- Granulomatous Disease, Chronic enzymology, Granulomatous Disease, Chronic genetics, Mycoses pathology, Staphylococcal Infections pathology, Staphylococcus aureus, Granulomatous Disease, Chronic complications, Mycoses etiology, NADPH Oxidase 2 genetics, NADPH Oxidase 2 metabolism, Phagocytes enzymology, Staphylococcal Infections etiology
- Abstract
Dysfunction of phagocytes is a relevant risk factor for staphylococcal infection. The most common hereditary phagocyte dysfunction is chronic granulomatous disease (CGD), characterized by impaired generation of reactive oxygen species (ROS) due to loss of function mutations within the phagocyte NADPH oxidase NOX2. Phagocytes ROS generation is fundamental to eliminate pathogens and to regulate the inflammatory response to infection. CGD is characterized by recurrent and severe bacterial and fungal infections, with Staphylococcus aureus as the most frequent pathogen, and skin and lung abscesses as the most common clinical entities. Staphylococcus aureus infection may occur in virtually any human host, presumably because of the many virulence factors of the bacterium. However, in the presence of functional NOX2, staphylococcal infections remain rare and are mainly linked to breaches of the skin barrier. In contrast, in patients with CGD, S. aureus readily survives and frequently causes clinically apparent disease. Astonishingly, little is known why S. aureus, which possesses a wide range of antioxidant enzymes (e.g. catalase, SOD), is particularly sensitive to control through NOX2. In this review, we will evaluate the discovery of CGD and our present knowledge of the role of NOX2 in S. aureus infection., (© FEMS 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.